BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12664137)

  • 1. Assessment of response to therapy using conventional imaging.
    Rankin SC
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S56-64. PubMed ID: 12664137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do not abandon the bone marrow biopsy yet in diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC
    J Clin Oncol; 2015 Apr; 33(10):1217. PubMed ID: 25691675
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bone lymphoma].
    Merino Menéndez S; Vega González ML; Blanco Cabellos JA
    Sangre (Barc); 1998 Dec; 43(6):521-5. PubMed ID: 10089813
    [No Abstract]   [Full Text] [Related]  

  • 4. [Semiology of the exploration of residual masses in the mediastinum using imaging techniques].
    Pallardó Calatayud Y; Ferrer Puchol MD; García Conde J
    Sangre (Barc); 1998 Feb; 43(1):83-6. PubMed ID: 9577187
    [No Abstract]   [Full Text] [Related]  

  • 5. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
    Specht L
    Semin Radiat Oncol; 2007 Jul; 17(3):190-7. PubMed ID: 17591566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of positron emission tomography in diagnosing subcutaneous panniculitis-like T-cell lymphoma.
    Bennani-Baiti B; Yadav S; Flynt L; Bennani-Baiti N
    J Clin Oncol; 2015 Apr; 33(10):1216-7. PubMed ID: 25691676
    [No Abstract]   [Full Text] [Related]  

  • 7. New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.
    Cheson BD
    Radiol Clin North Am; 2008 Mar; 46(2):213-23, vii. PubMed ID: 18619377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT-Controlled Prospective Study in 64 Patients.
    Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Knogler T; Sillaber C; Jaeger U; Simonitsch-Klupp I; Ubl P; Müllauer L; Dolak W; Lukas J; Raderer M
    Clin Cancer Res; 2015 Jun; 21(11):2506-13. PubMed ID: 25733598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of PET imaging in lymphoma.
    Burton C; Ell P; Linch D
    Br J Haematol; 2004 Sep; 126(6):772-84. PubMed ID: 15352980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of FDG PET for therapy monitoring of malignant lymphoma--results of a retrospective study in 72 patients].
    Cremerius U; Fabry U; Kröll U; Zimny M; Neuerburg J; Osieka R; Büll U
    Nuklearmedizin; 1999; 38(1):24-30. PubMed ID: 9987778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography in the management of lymphomas: a summary.
    O'Doherty MJ; Hoskin PJ
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S128-30. PubMed ID: 12692689
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of initial lymphoma staging using computed tomography (CT) and magnetic resonance (MR) imaging.
    Hoane BR; Shields AF; Porter BA; Borrow JW
    Am J Hematol; 1994 Oct; 47(2):100-5. PubMed ID: 8092123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG PET in the management of lymphoma: a clinical perspective.
    Hoskin PJ
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):449-51. PubMed ID: 11914880
    [No Abstract]   [Full Text] [Related]  

  • 14. Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma.
    Vinnicombe SJ; Reznek RH
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S42-55. PubMed ID: 12709830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging for Staging and Response Assessment in Lymphoma.
    Johnson SA; Kumar A; Matasar MJ; Schöder H; Rademaker J
    Radiology; 2015 Aug; 276(2):323-38. PubMed ID: 26203705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study.
    Pelosi E; Penna D; Douroukas A; Bellò M; Amati A; Arena V; Passera R; Bisi G
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):469-75. PubMed ID: 21150862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphoma.
    Setoain FJ; Pons F; Herranz R; Vidal-Sicart S; Lomeña F; Ayuso C; Montserrat E; Setoain J
    Nucl Med Commun; 1997 May; 18(5):405-11. PubMed ID: 9194081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphography in management of lymphoma.
    Kiely JM; Miller WE; Scanlon PW
    Med Clin North Am; 1970 Jul; 54(4):939-49. PubMed ID: 5468046
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods].
    Pichler R; Maschek W; Hatzl-Griesenhofer M; Huber H; Wimmer G; Wahl G; Fridrik M
    Nuklearmedizin; 2000 Sep; 39(6):166-73. PubMed ID: 11057408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiological diagnostics of Hodgkin- and non-Hodgkin lymphomas of the thorax].
    Uffmann M; Schaefer-Prokop C
    Radiologe; 2004 May; 44(5):444-56. PubMed ID: 15114475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.